Research

In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of...

On a recent visit to Melbourne, Australia, Prof Amit Bar-Or (University of Pennsylvania) sat down with Prof Trevor Kilpatrick (University of Melbourne, Florey Institute of Neuroscience and Mental Health) to...

...

A newly published study from the University of Cambridge has found that fasting, as well as a common diabetes drug that mimics fasting, can improve myelin repair. In the below video, our co-founder and...

ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the video summaries from Day 1 and Day 2.  With the conference...

Recently, I arrived in the United Kingdom and headed north to the city of Liverpool.  While I’m a fan of The Beatles and a passionate Liverpool Football Club supporter in the Premier League, I had other...

In our most recent Facebook Live Q&A, once again facilitated by our co-founder and chief science communicator, Brett Drummond, a special announcement was made. We were excited to share that, for the second...

Research Summary: Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis Ask people living with multiple sclerosis what their worst symptom is and they will probably...

There is an increasing focus on the role that lifestyle changes may play in helping to manage multiple sclerosis. Factors such as diet, exercise, mindfulness, vitamin D levels and smoking habits are all...

On World MS Day 2019 (May 29), MStranslate co-founder and chief science communicator, Brett Drummond, took to Facebook Live to provide a comprehensive update on the latest developments in multiple sclerosis...